Articles Tagged With:
-
Acupuncture and Neuromodulation in the Treatment of Migraine
Individuals suffering with migraine often use complementary and integrative therapies to treat migraine symptoms. Acupuncture has moderate evidence in reducing the frequency of migraine attacks, and neuromodulation is a promising treatment on the horizon for those suffering with migraine.
-
Joint Arthrocentesis in the Emergency Department
The ability to rapidly recognize infection, as well as distinguish inflammatory arthropathy from infection, crystal arthropathy, and osteoarthritis, makes arthrocentesis a valuable and sometimes essential emergency medicine procedure.
-
What Is the Ideal Target for Blood Pressure Control?
Patient-reported outcomes in a recent trial of subjects who received intensive treatment with a target systolic blood pressure of < 120 mmHg were similar to those who received standard care, supporting the recommendations of SPRINT.
-
Cerebrolysin Is Unproven as a Neuroprotectant for Acute Ischemic Stroke
The routine use of Cerebrolysin in acute stroke is not justified.
-
Idarucizumab for Reversal of the Anticoagulant Effects of Dabigatran
The administration of idarucizumab is effective and safe for the reversal of the direct thrombin inhibitor, dabigatran, and should be used in appropriate clinical situations.
-
Sudden Prehospital Death From Subarachnoid Hemorrhage
Based on recent nationwide data reported from Finland, one-fourth of those experiencing their first ever subarachnoid hemorrhage died suddenly before being admitted to a hospital.
-
Infectious Disease Alert Updates
Corporate Antibiotic Stewardship; Hypervirulence Meets Antibiotic Resistance — A Lethal Combination; Glue Masquerading as an Aortic Root Abscess; Molecular Diagnostic Coup
-
California and Coccidioidomycosis: Be Careful About the Air You Breathe
Cases of coccidioidomycosis significantly increased in 2016.
-
Polyneuropathy and Nutrition
Other than the identification of a specific vitamin or essential element deficiency, overall nutritional status does not appear to play any role in the development of idiopathic neuropathies in adults.
-
Delafloxacin (Baxdela®)
Delafloxacin is a new broad-spectrum fluoroquinolone that was approved by the U.S. Food and Drug Administration in June 2017 for acute bacterial skin and skin structure infections.